Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ReutersLegal Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::334944709.png) Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100K followers
Created: 2025-07-23 22:15:12 UTC

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in XX countries next year, the Indian drugmaker's CEO, Erez Israeli, said on Wednesday.

![](https://pbs.twimg.com/card_img/1948144896965033984/-iZQbPk1?format=jpg&name=800x419)

**Related Topics**
[countries](/topic/countries)
[wegovy](/topic/wegovy)
[novo](/topic/novo)
[$drreddyns](/topic/$drreddyns)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/ReutersLegal/status/1948144895929024833)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ReutersLegal Avatar Reuters Legal @ReutersLegal on x 100K followers Created: 2025-07-23 22:15:12 UTC

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in XX countries next year, the Indian drugmaker's CEO, Erez Israeli, said on Wednesday.

Related Topics countries wegovy novo $drreddyns dr reddys

Post Link

post/tweet::1948144895929024833
/post/tweet::1948144895929024833